NNVC financials

NanoViricides (NNVC) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.

NNVC income statement, yearly

YearRevenueGross profitOperating incomeNet incomeEPS
2026––-$8.31M-$8.22M-0.41
2025––-$9.59M-$9.47M-0.63
2024––-$8.52M-$8.29M-0.70
2023––-$8.94M-$8.59M-0.74
2022––-$8.11M-$8.11M-0.70
2021––-$8.74M-$8.82M-0.81